Evidence map›Paper›PMID 42022519›Full record

ArticleRespirology case reports2026

Cytomegalovirus Pneumonia Requiring Intensive Care During Treatment for Rapidly Progressive Interstitial Lung Disease Associated With Anti-Synthetase Syndrome: A Case Report.

Hiroe Aramaki, Kiyomitsu Fukaguchi, Sachi Miyashita, Yuki Yao, Mizuki Sato, Shingo Ohki, Hiroshi Koyama, Satoshi Noma, Tomoya Fukui

Abstract read
In one paragraph

Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroe AramakiDepartment of Respiratory Medicine Shonan Kamakura General Hospital Kamakura-shi Kanagawa Japan.ORCID https://orcid.org/0000-0003-4166-1115
Kiyomitsu FukaguchiShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.ORCID https://orcid.org/0000-0003-2262-1898
Sachi MiyashitaShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.
Yuki YaoShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.
Mizuki SatoShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.
Shingo OhkiShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.ORCID https://orcid.org/0000-0001-8828-245X
Hiroshi KoyamaShonan Kamakura General Hospital Department of Critical Care Medicine Kamakura-shi Kanagawa Japan.
Satoshi NomaDepartment of Respiratory Medicine Shonan Kamakura General Hospital Kamakura-shi Kanagawa Japan.
Tomoya FukuiDepartment of Respiratory Medicine Shonan Kamakura General Hospital Kamakura-shi Kanagawa Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 70-year-old man presented with fever and malaise and was diagnosed with anti-synthetase syndrome based on chest computed tomography and laboratory findings. Steroid therapy was initiated because of progressive respiratory failure. However, despite steroid therapy, his respiratory status worsened, accompanied by expansion of ground-glass opacities (GGOs) on imaging. On hospital day 26, the patient developed severe respiratory failure, requiring mechanical ventilation and prone positioning, at which time cytomegalovirus (CMV) antigenemia was detected. After clinically diagnosing CMV pneumonia superimposed on interstitial lung disease (ILD), ganciclovir was initiated while gradually tapering corticosteroid therapy. This approach led to significant clinical and radiological improvements. The patient was successfully weaned from ventilation on day 30 and discharged on day 70. In patients with rapidly progressive ILD who deteriorate despite high-dose corticosteroids and develop new diffuse GGOs, superimposed CMV infection should be suspected and promptly evaluated. Early recognition and antiviral therapy are essential for improving outcomes.

Indexed as

anti‐synthetase syndromecytomegalovirus pneumoniarapidly progressive interstitial lung disease

Identifiers

PMID42022519
PMCPMC13097528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.